Records containing: Smoldering Multiple Myeloma (SMM)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 2 Study of Linvoseltamab in Patients With Smoldering Multiple Myeloma at High Risk of Progression to Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-04-08Phase 2 Dose-Ranging and Interception Study of Linvoseltamab in Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-04-03A Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-01-20CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-07-12Efficacy of Curcumin and Piperine in Patients on Active Surveillance for Either Monoclonal Gammopathy of Unknown Significance (MGUS), Low-risk Smoldering Multiple Myeloma (SMM) or Early Stage Prostate Cancer: A Pilot Study